Picture of Venture Life logo

VLG Venture Life Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+2.6%
3m+6.47%
6m+10.72%
1yr-13.55%
Volume Change (%)
10d/3m-60.36%
Price vs... (%)
52w High-15.91%
50d MA+1.28%
200d MA+10.69%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)5.78
PEG Ratio (f)0.37
EPS Growth (f)18.52%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value0.63
Price to Tang. Bookn/a
Price to Free Cashflow13.36
Price to Sales0.96
EV to EBITDA7.4

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital2.05%
Return on Equity-1.02%
Operating Margin4.47%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total Revenue£m18.7720.2130.0832.7643.9850.75522.33%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/a+109.71+155.32-20.19-58.08+442.17+18.52n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Venture Life EPS forecast chart

Profile Summary

Venture Life Group PLC is a United Kingdom-based consumer self-care company. The Company develops, manufactures and distributes products for the consumer self-care market. With operations in the United Kingdom, Italy, the Netherlands and Sweden, the Company's product portfolio includes products, such as the UltraDEX and Dentyl oral care product ranges; the Balance Activ range in the area of women's intimate healthcare; the Lift and Glucogel product ranges for hypoglycaemia; Gelclair, and Pomi-T for oncology support products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing. Its segments include Venture Life Brands and Customer Brands. Through its two Development and Manufacturing operations in Italy and Sweden, the Company also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

Directors

Last Annual
December 31st, 2022
Last Interim
June 30th, 2023
Incorporated
December 12th, 2005
Public Since
March 28th, 2014
No. of Employees
153
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
126,498,197

VLG Share Price Performance

Upcoming Events for VLG

Full Year 2023 Venture Life Group PLC Earnings Release

Venture Life Group PLC Annual Shareholders Meeting

Similar to VLG

Picture of Alliance Pharma logo

Alliance Pharma

gb flag iconLondon Stock Exchange

Picture of Animalcare logo

Animalcare

gb flag iconLondon Stock Exchange

Picture of AstraZeneca logo

AstraZeneca

gb flag iconLondon Stock Exchange

Picture of Beximco Pharmaceuticals logo

Beximco Pharmaceuticals

gb flag iconLondon Stock Exchange

Picture of BSF Enterprise logo

BSF Enterprise

gb flag iconLondon Stock Exchange

FAQ